Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Pulmonary Hypertension Associated With Sickle Cell Disease
NCT00313196Phase 3Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Apr 2006
- Primary completion
- Aug 2007
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
A Phase 3 trial of bosentan in pulmonary hypertension (PH), sponsored by Actelion Pharmaceuticals Ltd. Started Apr 2006; status: terminated.
02
Drugs
bosentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00313196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313196.